Kingdon Capital Management, L.L.C. Intercept Pharmaceuticals, Inc. Put Options Transaction History

Kingdon Capital Management, L.L.C.

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$77.77 - $120.68 $7.78 Million - $12.1 Million	-100,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $9.18 Million - $12.1 Million	100,000 New	100,000 $11.2 Million

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Kingdon Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Kingdon Capital Management, L.L.C. with notifications on news.